section name header
Index
Adverse Effects of Amiodarone
Air Travel and Prevention of Venous Thromboembolism by Medication
Anticoagulants for Non-Rheumatic Atrial Fibrillation and a History of Stroke or Transient Ischaemic Attacks
Anticoagulant Therapy in Acute (Duration Less Than 48 Hours) Atrial Fibrillation
Anticoagulation for Heart Failure in Sinus Rhythm
Anticoagulation for the Long Term Treatment of Venous Thromboembolism in Patients with Cancer
Antiplatelet and Anticoagulant Agents for Secondary Prevention of Stroke and other Thromboembolic Events in People with Antiphospholipid Syndrome
Antiplatelet Drugs for Prevention of Restenosis after Peripheral Endovascular Treatment
Antiplatelet Therapy for Patients with Non-Valvular Atrial Fibrillation
Antithrombotic Agents in Primary Health Care - Related Resources
ASA for Hypertension
Cardiology
Cochrane review
Dabigatran Versus Lmwhs for Thromboprophylaxis after Total Hip or Knee Replacement
Dabigatran Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation
Deep Vein Thrombosis - Related Resources
Direct Oral Anticoagulants Versus Vitamin K Antangonists in Non-Valvular Atrial Fibrillation
Direct Oral Anticoagulants Versus Warfarin Among Atrial Fibrillation Patients with Chronic Kidney Disease
Evidence summary
Extended DVT Prophylaxis after Hospital Discharge in Patients with Elective Hip Arthroplasty
Factor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Embolism in Patients with Atrial Fibrillation
Haematology
Indications for and Implementation of Anticoagulant Therapy in Atrial Fibrillation - Related Resources
Internal medicine
Low-Dose Warfarin for Atrial Fibrillation
Low-Intensity Warfarin for Long-Term Prevention of Venous Thromboembolism
Medical Treatment to Increase Patency of Arteriovenous Fistulae and Grafts
Melatonin for Preventing and Treating Jet Lag
Neurology
Noac Versus Warfarin Postpci in Atrial Fibrillation
Optimal Loading Dose of Warfarin for the Initiation of Oral Anticoagulation
Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease
Oral Anticoagulants Vs Antiplatelet Therapy for Preventing Stroke in Patients with Non-Valvular Atrial Fibrillation and No History of Stroke or TIA
Oral Anticoagulation for Prolonging Survival in Patients with Cancer
Oral Direct Thrombin Inhibitors or Oral Factor Xa Inhibitors for the Treatment of Pulmonary Embolism
Pharmacology
Prevention of Venous Thromboembolism - Related Resources
Primary Prophylaxis for Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy
Selecting Anticoagulant Therapy in Atrial Fibrillation
Stroke Risk in Patients with Atrial Fibrillation and Heart Failure
Surgery
Systematic review
Treatment of Deep Venous Thrombosis
Vitamin K Antagonists or Low-Molecular Weight Heparin for Venous Thromboembolism
Vitamin K Antagonists Versus Antiplatelet Therapy after TIA or Minor Ischaemic Stroke of Presumed Arterial Origin
Vitamin K for Improved Anticoagulation Control in Patients Receiving Warfarin
Warfarin for Preventing Stroke in Patients with Non-Valvular Atrial Fibrillation and No History of Cerebral Ischaemia
Warfarin Initiation Nomograms for Venous Thromboembolism
Warfarin or Antiplatelet Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
Warfarin Therapy
Warfarin Therapy - Related Resources